Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Operating Leases (2022 - 2026)

HeartSciences' Operating Leases history spans 5 years, with the latest figure at $211917.0 for Q1 2026.

  • For Q1 2026, Operating Leases fell 38.72% year-over-year to $211917.0; the TTM value through Jan 2026 reached $211917.0, down 38.72%, while the annual FY2025 figure was $314527.0, 27.54% down from the prior year.
  • Operating Leases reached $211917.0 in Q1 2026 per HSCS's latest filing, down from $247263.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $583016.0 in Q1 2023 to a low of $211917.0 in Q1 2026.
  • Average Operating Leases over 5 years is $410401.2, with a median of $419894.0 recorded in 2024.
  • Peak YoY movement for Operating Leases: decreased 11.35% in 2023, then tumbled 38.72% in 2026.
  • A 5-year view of Operating Leases shows it stood at $549227.0 in 2022, then dropped by 11.35% to $486885.0 in 2023, then decreased by 22.72% to $376241.0 in 2024, then plummeted by 34.28% to $247263.0 in 2025, then fell by 14.29% to $211917.0 in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Operating Leases are $211917.0 (Q1 2026), $247263.0 (Q4 2025), and $281570.0 (Q3 2025).